JW Pharmaceutical

001060 · KOSPI · Health Care · SMALL CAP

An acquisition.

JW Pharmaceutical disclosed an acquisition of Solidus Investment Co., Ltd., worth US$22.8M.

M&A(Decision to acquire shares/equity in another company)· FILED 2026-09-29· RCEPT 20260929800726

US$22.8MDeal value
5.1%vs. company assets

Converted at 1 USD ≈ ₩1,350.5 (filing-date rate, 2026-09-29 close)

What happened

JW Pharmaceutical disclosed an acquisition of Solidus Investment Co., Ltd., worth US$22.8M.

For context, this deal is worth about 5.1% of the company's own total assets.

TargetSolidus Investment Co., Ltd.
Deal valueUS$22.8M
vs. company assets5.1%
Filed2026-09-29, Decision to acquire shares/equity in another company
SourceDART rcept 20260929800726 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-29 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.